FibroBiologics Q2 EPS $0.03 Beats $(0.09) Estimate; Cash $5.973M
FibroBiologics Q2 EPS $0.03 Beats $(0.09) Estimate; Cash $5.973M
FibroBiologics第二季度每股收益为0.03美元，超过了-0.09美元的预期；现金为597.3万美元
FibroBiologics, Inc. - Common Stock (NASDAQ:FBLG) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.09) by 133.33 percent. This is a 137.5 percent increase over losses of $(0.08) per share from the same period last year.
Fibrobiologics, Inc.——普通股（纳斯达克股票代码：FBLG）公布的季度收益为每股0.03美元，比分析师普遍预期的0.09美元（0.09美元）高出133.33％。与去年同期每股亏损0.08美元（0.08）相比，增长了137.5％。